Short answer
Ginkgo Bioworks Holdings, Inc. (DNA) filed an 8-K current report with the SEC on April 7, 2026 reporting Item 2.01 (Completion of Acquisition or Disposition of Assets), Item EX-99.1 (Exhibit EX-99.1). Biosecurity segment transferred to Perimeter Systems, marking Ginkgo’s exit from substantially all Biosecurity operations.
Ginkgo Bioworks Holdings, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.01 · Completion of Acquisition or Disposition of Assets
- Biosecurity segment transferred to Perimeter Systems, marking Ginkgo’s exit from substantially all Biosecurity operations
- Ginkgo received approximately 20% of Perimeter Systems’ fully diluted equity instead of cash proceeds
- Transaction completed April 3, 2026 under the February 26, 2026 Stock Purchase Agreement
- Biosecurity qualifies as discontinued operations under ASC 205-20, reshaping reported historical financials
- Pro forma balance sheet and operations statements cover 2025, 2024, and 2023 for comparability
Item EX-99.1 · Exhibit EX-99.1
- Biosecurity operations transferred to Tower Biosecurity for approximately 20% fully diluted ownership, creating an equity-method investment
- Pro forma revenue falls to $132.7M in 2025 from $170.2M as $37.4M Biosecurity revenue is removed
- Pro forma 2025 net loss improves to $287.8M from $312.8M after eliminating Biosecurity expenses
- Purchaser investment adds $12.3M to assets, while pro forma equity rises to $515.9M
- Biosecurity results reclassified as discontinued operations beginning with the March 31, 2026 10-Q
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Ginkgo Bioworks Holdings, Inc. 8-K filings
Get the next DNA 8-K as it lands
Follow DNA for push alerts, or ask the research agent what this filing means.